318
Participants
Start Date
August 1, 2018
Primary Completion Date
September 1, 2019
Study Completion Date
September 1, 2021
concurrent chemoradiotherapy (CCRT)
"Chemotherapy: Cisplatin (50 mg/m2) on days 1, 8, 29, and 36 and etoposide (50mg/m2) on days 1~5 and 29~33.~Radiotherapy: Thoracic radiotherapy (TRT) started with a linear accelerator (6MV-X) on the first day of chemotherapy.A minimum dose of 60 Gy (2 Gy per fraction, Monday~Friday) was delivered, and a range of 60-66 Gy in 2 Gy fractions was allowed."
Endostar for one cycle
Endostar(15mg/m2) was durative transfused during the normalization window of the first chemoradiotherapy cycle(days -5~-1).
Endostar for two cycles
Endostar(15mg/m2) was durative transfused during the normalization window of the first and the second chemoradiotherapy cycles(days -5~-1 and 24~28).
Affiliated Hospital of North Sichuan Medical College, Nanchong
Collaborators (1)
Jiangsu Simcere Pharmaceutical Co., Ltd.
INDUSTRY
Affiliated Hospital of North Sichuan Medical College
OTHER